Literature DB >> 8481214

Contraceptive choice for women with 'risk factors'.

I S Fraser1.   

Abstract

Women with many medical conditions need to plan their families with special care. For such women, the risk of complications with particular contraceptive methods is increased. Women with severe hypertension, a previous myocardial infarction or venous thromboembolism, or cerebrovascular stroke have a significant risk of problems in pregnancy, and should avoid the combined pill. The combined pill may increase the risk of cardiovascular disease in patients with diabetes mellitus and may worsen the severity of migrainous headaches in susceptible patients. Women with active hepatitis should wait for liver function tests to normalise before becoming pregnant or starting the combined pill or injectable progestogen. Control of epilepsy may deteriorate with use of the combined pill; this is probably because of the risk of drug interactions. Similarly, contraceptive control may also fail in women receiving rifampicin (rifampin) concurrently with contraceptive steroids. Intrauterine contraceptive devices should not be used in women who have experienced previous episodes of pelvic inflammatory disease, or with previous malignancy of the genital tract until complete cure is likely. Other conditions which may appear, become more common or worsen when the combined pill is prescribed include hepatic adenoma, gall bladder disease, ulcerative colitis, alopecia, hirsutism and acne. Some of these conditions are potentially hazardous to the woman's health, in which case combined pill use should be stopped. If the condition is unchanged then the combined pill may sometimes be reintroduced with caution.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8481214     DOI: 10.2165/00002018-199308040-00002

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  9 in total

1.  Mortality associated with the control of fertility.

Authors:  C Tietze; J Bongaarts; B Schearer
Journal:  Fam Plann Perspect       Date:  1976 Jan-Feb

2.  A decade of intrauterine contraception: 1976 to 1986.

Authors:  H J Tatum; E B Connell
Journal:  Fertil Steril       Date:  1986-08       Impact factor: 7.329

3.  The organization and results of a pregnancy termination service in a National Health Service hospital.

Authors:  M G Hull; C Gordon; R W Beard
Journal:  J Obstet Gynaecol Br Commonw       Date:  1974-08

4.  Noncontraceptive health benefits of oral steroidal contraceptives.

Authors:  D R Mishell
Journal:  Am J Obstet Gynecol       Date:  1982-03-15       Impact factor: 8.661

5.  The noncontraceptive health benefits from oral contraceptive use.

Authors:  H W Ory
Journal:  Fam Plann Perspect       Date:  1982 Jul-Aug

Review 6.  A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.

Authors:  I S Fraser; E Weisberg
Journal:  Med J Aust       Date:  1981-01-24       Impact factor: 7.738

Review 7.  Contraception and the "high-risk" woman.

Authors:  S K Khoo; J F Correy
Journal:  Med J Aust       Date:  1981-01-24       Impact factor: 7.738

8.  Microsurgical reversal of female sterilization: a reappraisal.

Authors:  V Gomel
Journal:  Fertil Steril       Date:  1980-06       Impact factor: 7.329

9.  Barrier-method contraceptives and pelvic inflammatory disease.

Authors:  J Kelaghan; G L Rubin; H W Ory; P M Layde
Journal:  JAMA       Date:  1982-07-09       Impact factor: 56.272

  9 in total
  3 in total

1.  Family planning requirements in the adult congenital heart disease clinic.

Authors:  H Leonard; J J O'Sullivan; S Hunter
Journal:  Heart       Date:  1996-07       Impact factor: 5.994

Review 2.  The management of pregnancy in hypertensive patients.

Authors:  R D Tunbridge
Journal:  Postgrad Med J       Date:  1994-11       Impact factor: 2.401

3.  Normal delivery following resection of an androgen-secreting adrenal carcinoma.

Authors:  Toshiyasu Amano; Tetsuya Imao; Masaya Seki; Katsurou Takemae; Keishi Yamauchi; Satoru Hata
Journal:  Reprod Med Biol       Date:  2010-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.